Profound Medical Corp T.PRN

Alternate Symbol(s): PROF

Healthcare Medical Devices

Profound Medical Corp. is a Canada-based commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. It is commercializing TULSA-PRO, a technology that combines real-time magnetic resonance imaging (MRI), robotically driven transurethral ultrasound and closed-loop temperature feedback control. The TULSA procedure, performed using the TULSA-PRO system, has the potential of becoming a mainstream treatment modality across the entire prostate disease spectrum; ranging from low -, intermediate-, or high-risk prostate cancer; to hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (BPH); to men with BPH only; and also, to patients requiring salvage therapy for radio-recurrent localized prostate cancer. It is also commercializing Sonalleve, a therapeutic platform that is CE marked for the treatment of uterine fibroids and palliative pain treatment of bone metastases.

TSX:PRN - Post by User

Profound Medical Corp

<< Previous

Bullboard Posts

Next >>

Post by HomerAndCompanyon Nov 05, 2021 11:52am

200 Views

Post# 34092304

Down due to slow growth, Procept IPO, tax loss selling, or..

1) As the Q3 report would seem to have triggered this sell-off it makes sense to blame the slower than projected growth in installed base, and corresponding slow revenue growth (that Profound blames on COVID of course).

2) The Procept Biorobotics IPO was mentioned in the Q3 Financial Results conference call. More competition could be hurting the share price though the Porocept IPO was back on June 30th and you might think would already be factored in.

3) If tax loss sellers were looking for an opportunity to sell low, today looks good for that.

Please feel free to add your own reasons for the share price drop and/or refute mine. -TIA

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Nov. 22, 2024)